Table 1.
Baseline characteristics of the RDT-PEF population.
| Total (n = 25) | RDT (n = 17) | Control (n = 8) | P (RDT vs. Control) | |
|---|---|---|---|---|
| Demographics | ||||
| Age | 74.3 ± 6.1 | 74.1 ± 6.8 | 74.6 ± 4.8 | 0.852 |
| Male | 15 (60%) | 11 (64.7%) | 4 (50.0%) | 0.667 |
| BMI (kg/m2) | 30.6 ± 5.5 | 30.5 ± 4.6 | 30.8 ± 7.4 | 0.911 |
| Past medical history | ||||
| Hypertension | 18 (72%) | 14 (82.4%) | 4 (50%) | 0.156 |
| Diabetes | 10 (40%) | 8 (47.1%) | 2 (25%) | 0.402 |
| CVA | 1 (4%) | 1 (5.9%) | 0 (0.0%) | 1.000 |
| CHD | 6 (24%) | 5 (29.4%) | 1 (12.5%) | 0.624 |
| AF | 15 (60%) | 10 (58.8%) | 5 (62.5%) | 1.000 |
| Medications | ||||
| ACEi/ARB | 23 (92%) | 16 (94.1%) | 7 (87.5%) | 1.000 |
| Beta-blockers | 18 (72%) | 12 (70.6%) | 6 (75%) | 1.000 |
| CC-blockers | 8 (32%) | 7 (41.2%) | 1 (12.5%) | 0.205 |
| Loop diuretics | 21 (84%) | 16 (94.1%) | 5 (62.5%) | 0.081 |
| Spironolactone | 6 (24%) | 6 (35.3%) | 0 (0.0%) | 0.129 |
Data are presented as mean ± standard deviation or count (%).
BMI: body mass index; CVA: cerebrovascular accident; CHD: coronary heart disease; AF: atrial fibrillation; NYHA: New York Heart Association; A: ambulatory; SBP: systolic blood pressure; ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CC: calcium channel.